endpoint_margin
TL2 Member · Reading, UK
Practical questions, practical answers. Not interested in speculation without a source.
Joined 6 September 2025 · last posted 2d · groups: regional-na
84 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #95 · Lounge › Introductions · 26 Jul 2026 · 20 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
What a certificate commits its issuer to Replied, post #105 · Analytics › COA interpretation · 25 Jul 2026 · 15 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #88 · Compounds › Retatrutide · 24 Jul 2026 · 7 likes What I would check first on retatrutide discussion is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Alcohol: what is documented and what is folklore Replied, post #129 · Practice › Interactions · 23 Jul 2026 · 0 likes I had written a reply contradicting post #127 and deleted it. Here is what survived. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #58 · Sourcing › Regulatory · 23 Jul 2026 · 3 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Follow-up: Signs of dehydration worth acting on Replied, post #33 · Safety › Adverse events · 21 Jul 2026 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Athletes in weight-category sports: a different risk calculus Replied, post #31 · Clinical › Special populations · 18 Jul 2026 · 0 likes Athletes in weight-category sports has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #80 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes Post #77 is the version of this I will quote in future. One addition. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #9 · Compounds › Tirzepatide · 18 Jul 2026 · 4 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #20 · Practice › Side effects · 16 Jul 2026 · 0 likes Post #16 and I disagree about the size of the effect, not about the direction. Adding a reference point for Taste changes and food aversion. Mine is a single case,…
-
What steady state means for the decision to escalate Replied, post #27 · Practice › Dosing & titration · 11 Jul 2026 · 14 likes A note on how steady state gets discussed rather than on steady state itself: the confident posts get the replies and the careful ones get ignored, and the careful ones…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #86 · Analytics › Home & field testing · 8 Jul 2026 · 0 likes On post #84 — agreed on the reasoning, with one qualification. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #42 · Analytics › Impurities & related substances · 2 Jul 2026 · 0 likes Peptide impurities that differ by a single residue are the hardest to resolve and the most likely to be biologically relevant, which is an unfortunate combination.…
-
Electrolyte supplements: which ones do anything Replied, post #32 · Nutrition & Training › Hydration & electrolytes · 16 Jun 2026 · 11 likes People with renal impairment or on medicines affecting electrolyte handling are exactly the group for whom generic advice is inappropriate.
-
Why a pen's dose steps are fixed and what that costs you Started this topic · Devices › Pens & autoinjectors · 7 Jun 2026 · 0 likes The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. A question about…
-
A site rotation scheme that is easy enough to actually follow Replied, post #75 · Practice › Administration · 29 May 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
-
Injection volume, overload, and peak distortion Replied, post #25 · Analytics › HPLC & UHPLC · 29 May 2026 · 6 likes The arithmetic in post #22 is right; the assumption feeding it is the part to check. An observation about injection volume that I cannot explain and am posting anyway,…
-
Request: a per-category review queue Replied, post #4 · Meta › Feature requests · 25 May 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. I would be cautious about generalising from the per-category review queue example above.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #86 · Compounds › Tirzepatide · 25 May 2026 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed Tirzepatide and nausea, as opposed to read about it? The thread is long and I cannot…
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #19 · Data & Tools › Datasets · 22 May 2026 · 2 likes Post #18 is the version of this I will quote in future. One addition. Units in the column header, always, and the same units down the whole column. Mixed units in one…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #49 · Compounds › Semaglutide · 4 May 2026 · 24 likes Molecular mass of semaglutide came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Requesting a translation of an existing page — the long version Replied, post #6 · Documentation › Wiki requests · 1 May 2026 · 0 likes Post #2 describes the usual case. This is about the unusual one. If a request is declined, the reasoning is written down, and it is worth reading because it usually…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #10 · Devices › Syringes & needles · 7 Apr 2026 · 13 likes The reason 0.3 ml versus 0.5 ml is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other…
-
Follow-up: State-level differences that actually matter Replied, post #40 · Regional › North America · 6 Apr 2026 · 0 likes Worth separating two things that post #36 runs together. My experience of State-level differences contradicts the reply above. I am posting it as a data point rather…
-
Sample handling between despatch and injection Replied, post #18 · Analytics › Method validation · 4 Apr 2026 · 5 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #28 · Evidence › Trials · 12 Mar 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Choosing which test to pay for, given a fixed budget Replied, post #20 · Sourcing › Independent verification · 10 Mar 2026 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. A partial answer, offered…
-
Whether protein timing matters at a large deficit Replied, post #31 · Nutrition & Training › Protein & intake · 6 Mar 2026 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #67 · Evidence › Study critique · 19 Feb 2026 · 27 likes Coming back to post #66, because the follow-up matters more than the original answer. Generalisability and validity are separate axes. A trial can be internally…
-
Heterogeneity as information rather than as a nuisance Replied, post #93 · Evidence › Meta-analyses · 7 Feb 2026 · 2 likes Having read the whole heterogeneity thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #81 · Access › International · 30 Jan 2026 · 4 likes Post #79 is right about the mechanism and I think understates the practical bit. The most useful thing anyone can add to a thin regional thread is what the official…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #12 · Clinical › Special populations · 21 Jan 2026 · 0 likes The practical version of Pregnancy and pregnancy planning is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #79 · Practice › Side effects · 20 Jan 2026 · 22 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #62 · Access › International · 18 Jan 2026 · 19 likes Post #59 put the caveat in the right place and I want to underline it. Regulatory position dates: a regulatory position is only current as of when it was written.…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #48 · Sourcing › Regulatory · 9 Jan 2026 · 0 likes Adding a null result on compound being unapproved. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Preprint servers and what screening they do Replied, post #11 · Evidence › Preprints · 30 Dec 2025 · 14 likes Taking post #8 at face value and following it one step further. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #61 · Practice › Side effects · 28 Dec 2025 · 3 likes Narrowing post #59, because the general version has more than one answer. The relationship between symptom burden and outcome is not what people assume. Feeling worse…
-
Tracking a preprint to publication: a worked example Replied, post #31 · Evidence › Preprints · 2 Dec 2025 · 8 likes Following this. I have the same question and no better information than the first post.
-
What a purity-only report leaves out Replied, post #93 · Sourcing › Independent verification · 19 Nov 2025 · 6 likes I think the purity-only question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
[2026 update] What steady state means for the decision to escalate Replied, post #20 · Practice › Dosing & titration · 6 Nov 2025 · 0 likes Worth separating two things that post #18 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #76 · Safety › Adverse events · 31 Oct 2025 · 0 likes The most useful contribution to this subcategory is a completed account: what happened, what was done, and what the outcome was. If it helps: the failure mode here is…
-
A 40-week log with the measurement method stated Replied, post #67 · Outcomes › Progress reports · 25 Oct 2025 · 0 likes Post #64 answers the question as asked. The question underneath it is different. A plateau over two weeks is usually measurement. A plateau over two months is usually…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #129 · Compounds › Tirzepatide · 24 Oct 2025 · 2 likes Where I part company with post #127, and it is a narrow parting. Taking SURMOUNT-4 seriously for a moment rather than deflecting: the honest position is that the…
-
Documentation that appears only after payment Replied, post #56 · Sourcing › Red flags · 23 Oct 2025 · 24 likes Post #52 put the caveat in the right place and I want to underline it. Filing a mild objection to the consensus on documentation. Mild because I might be wrong; an…
-
High-resolution MS on aggregates and what it can see Replied, post #100 · Analytics › Mass spectrometry · 23 Oct 2025 · 12 likes A request rather than an answer: could whoever has the primary source for high-resolution post it? I have seen the claim three times this month and each version had…
-
Research-use-only labelling: what it means and what it does not Replied, post #47 · Sourcing › Regulatory · 18 Oct 2025 · 15 likes Post #44 is right about the mechanism and I think understates the practical bit. If you can confirm or contradict a position for your own region, please date the…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #12 · Clinical › Special populations · 12 Oct 2025 · 0 likes Older adults were included in the trials in smaller numbers than their share of the eventual population, so precision in that subgroup is poor.
-
Second pass at: The mass-error checker and its intended scope Replied, post #33 · Data & Tools › Calculators · 7 Oct 2025 · 27 likes Coming back to post #31, because the follow-up matters more than the original answer. Precision and significant figures: the calculators do not round to match your…
-
Washout: how long is long enough, and for what purpose Replied, post #69 · Pharmacology › Pharmacokinetics · 22 Sep 2025 · 3 likes Something worth flagging about washout: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #67 · Practice › Administration · 18 Sep 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Realistic expectations for strength while losing weight quickly Replied, post #20 · Nutrition & Training › Resistance training · 12 Sep 2025 · 21 likes Joint comfort frequently improves with weight reduction, and members here report being able to train in ways they previously could not. The general case is well…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #35 · Analytics › Method validation · 6 Sep 2025 · 22 likes Post #31 put the caveat in the right place and I want to underline it. LOD and LOQ was covered in the wiki last year and the page has a review date on it, which is a…
-
Managing an unplanned gap in supply — what changed since Replied, post #53 · Access › Shortages · 3 Sep 2025 · 8 likes I read post #51 twice before replying, because I had assumed the opposite. Where an alternative within the class is available, the comparison is a clinical one and the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #112 · Practice › Reconstitution · 25 Aug 2025 · 5 likes That is the distinction I keep failing to hold on to. Written down now.
-
Enforcement priorities versus written rules — does this still hold? Replied, post #6 · Sourcing › Regulatory · 10 Aug 2025 · 0 likes On post #2 — agreed on the reasoning, with one qualification. Approval versus licensing: a compound can be approved for a specific indication in one country and not…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #10 · Compounds › Secretagogues & GH axis · 24 Jul 2025 · 0 likes Post #7 answers the question as asked. The question underneath it is different. Evidence quality in the secretagogue literature is honestly weaker than in the incretin…
-
Follow-up: The topic list is dense — is that deliberate? Replied, post #5 · Meta › Site feedback · 15 Jul 2025 · 3 likes Suggestion rather than complaint: the vendor pages carry a review date, and topics do not. A topic that has been read by a maintainer recently is a different thing from…
-
Regression to the mean in progress reports Replied, post #29 · Research Methods › Statistics · 6 Jul 2025 · 13 likes Rounding and significant figures carry information about precision. A figure quoted to four significant figures from a method with two per cent variability is…
-
Repeatability versus intermediate precision Replied, post #96 · Analytics › Method validation · 29 Jun 2025 · 5 likes The useful distinction on repeatability versus intermediate precision is between what was measured and what was inferred from it. Both end up in the same sentence and…
-
The storage lookup and where its data comes from Replied, post #4 · Data & Tools › Calculators · 22 Jun 2025 · 0 likes Post #3 is the version of this I will quote in future. One addition. What I can speak to on storage lookup is narrow, so I will keep it narrow rather than generalising…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #18 · Clinical › Special populations · 3 Jun 2025 · 21 likes Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that need an individual assessment.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #122 · Compounds › Cagrilintide & amylin analogues · 26 May 2025 · 0 likes Reporting rather than recommending, on amylin analogue mechanism. What happened is above. Whether it should have is a different question and not one I am qualified to…
-
Coverage for the indication versus for the drug Replied, post #60 · Access › Insurance & coverage · 10 May 2025 · 18 likes On post #59 — agreed on the reasoning, with one qualification. Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking…
-
Deamidation and the close-eluting pair it produces Replied, post #34 · Analytics › Impurities & related substances · 29 Apr 2025 · 20 likes What I would check first on deamidation is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
What a 2 ppm match establishes, and what it does not Replied, post #8 · Analytics › Mass spectrometry · 29 Mar 2025 · 0 likes If someone has run 2 ppm match properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Follow-up: Requesting a page: what makes a good request Replied, post #15 · Documentation › Wiki requests · 28 Mar 2025 · 30 likes Useful. I have added it to my own notes with the date on it.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #31 · Outcomes › Progress reports · 25 Mar 2025 · 0 likes I read post #27 twice before replying, because I had assumed the opposite. For anyone finding this later: the short answer on 18-month record is that it depends on one…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #55 · Sourcing › Red flags · 20 Feb 2025 · 0 likes I had written a reply contradicting post #53 and deleted it. Here is what survived. Nothing here should be read as an accusation against a named company, and the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #111 · Compounds › Semaglutide · 20 Feb 2025 · 21 likes The arithmetic in post #109 is right; the assumption feeding it is the part to check. The mass figure differs between sources because of how the different entities…
-
UK access routes, dated and sourced — a second dataset Replied, post #36 · Regional › UK & Ireland · 8 Feb 2025 · 0 likes Adding the measurement that post #35 says would settle it. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #37 · Evidence › Meta-analyses · 1 Feb 2025 · 11 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #48 · Compounds › Oral incretins · 13 Jan 2025 · 0 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #97 · Compounds › Semaglutide · 25 Dec 2024 · 17 likes Coming back to post #93, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #6 · Practice › Reconstitution · 27 Nov 2024 · 11 likes The arithmetic in post #5 is right; the assumption feeding it is the part to check. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Washout with a one-week half-life: the arithmetic Replied, post #24 · Research Methods › N-of-1 designs · 27 Nov 2024 · 4 likes The most useful thing anyone has posted about washout in this category was a table of what had been measured and by whom. That is what I would want again.
-
US compounding rules and how they changed Replied, post #59 · Regional › North America · 6 Nov 2024 · 2 likes This follows post #56 rather than contradicting it. Appeals succeed more often than people expect when they answer the stated criterion point by point and include…
-
Time to steady state after a dose increase Replied, post #91 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 31 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #24 · Evidence › Journal club · 4 Nov 2024 · 17 likes A request rather than an answer: could whoever has the primary source for SURPASS-2 post it? I have seen the claim three times this month and each version had lost a…
-
UK access routes, dated and sourced — a second dataset Started this topic · Regional › UK & Ireland · 17 Oct 2024 · 49 likes Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Regional question, dated…
-
Individual participant data versus aggregate data Replied, post #4 · Evidence › Meta-analyses · 9 Oct 2024 · 1 like Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Requesting a page: what makes a good request — what changed since Replied, post #4 · Documentation › Wiki requests · 9 Oct 2024 · 12 likes Worth separating two things that post #2 runs together. Requests for a page summarising a supplier are declined, because that is what the vendor documentation set is…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #31 · Analytics › Mass spectrometry · 16 Aug 2024 · 13 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. The…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #109 · Compounds › Retatrutide · 23 Jul 2024 · 17 likes On Retatrutide dose escalation: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
-
The mass-error checker and its intended scope Replied, post #96 · Data & Tools › Calculators · 4 Jul 2024 · 6 likes Right — I had this wrong and I am glad to have read it before it mattered.